Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Pharmacological Research
|
June 25, 2011
Nonparametric population modeling and Bayesian analysis
Roger Jelliffe, Michael Neely, Alan Schumitzky, et al.
AIDS Research and Human Retroviruses
|
August 17, 2010
Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead
Aditya H Gaur, Marvin Belzer, Paula Britto, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers
Michael Neely, Laurent Decosterd, Aurélie Fayet, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
May 18, 2011
Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study
Patricia A Garvie, Patricia M Flynn, Marvin Belzer, et al.
Plos One
|
February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations
Arnold Louie, Michael Neely, Sarah Kim, et al.
Jac-Antimicrobial Resistance
|
January 23, 2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy
Veena Venugopalan, Nicole Maranchick, Devorah Hanai, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2022
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype
Walter Yamada, Sarah Kim, Mohammed Almoslem, et al.
International Journal of Antimicrobial Agents
|
September 22, 2015
Characterisation of a multidrug-resistant meningitic Escherichia coli strain (O75:K1:H5) isolated from an infant that is sensitive to memantine, a newly identified host-directed antimicrobial drug
Shifu Wang, Xiaolong He, Jing-Yi Yu, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Pharmacological Research
|
June 25, 2011
Nonparametric population modeling and Bayesian analysis
Roger Jelliffe, Michael Neely, Alan Schumitzky, et al.
AIDS Research and Human Retroviruses
|
August 17, 2010
Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead
Aditya H Gaur, Marvin Belzer, Paula Britto, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model
G L Drusano, Jenny Myrick, Michael Maynard, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
Activity of Moxifloxacin against <i>Mycobacterium tuberculosis</i> in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model
Arnold Louie, Brandon Duncanson, Jenny Myrick, et al.
Antimicrobial Agents and Chemotherapy
|
September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers
Michael Neely, Laurent Decosterd, Aurélie Fayet, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
|
May 18, 2011
Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study
Patricia A Garvie, Patricia M Flynn, Marvin Belzer, et al.
Plos One
|
February 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations
Arnold Louie, Michael Neely, Sarah Kim, et al.
Jac-Antimicrobial Resistance
|
January 23, 2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy
Veena Venugopalan, Nicole Maranchick, Devorah Hanai, et al.
Antimicrobial Agents and Chemotherapy
|
September 27, 2022
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype
Walter Yamada, Sarah Kim, Mohammed Almoslem, et al.
International Journal of Antimicrobial Agents
|
September 22, 2015
Characterisation of a multidrug-resistant meningitic Escherichia coli strain (O75:K1:H5) isolated from an infant that is sensitive to memantine, a newly identified host-directed antimicrobial drug
Shifu Wang, Xiaolong He, Jing-Yi Yu, et al.
Page
of 10